Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 117

Related Citations for PubMed (Select 23536351)

1.

[Impact of sleeve gastrectomy with ileal interposition duodenojejunal bypass operation on lipid metabolism in non-obese type 2 diabetes mellitus patients].

Yang YH, Yan J, Wu YJ, Lin Y, Yue XL.

Zhonghua Wei Chang Wai Ke Za Zhi. 2013 Mar;16(3):273-5. Chinese.

PMID:
23536351
2.

[Improvement of islet β-cell function after sleeve gastrectomy with ileal interposition duodenojejunal bypass in non-obese type 2 diabetes mellitus].

Yang Y, Yan J, Wu Y, Lin Y, Yue X.

Zhonghua Wei Chang Wai Ke Za Zhi. 2014 Jul;17(7):651-4. Chinese.

PMID:
25070441
3.

Impact on dyslipidemia of the laparoscopic ileal interposition associated to sleeve gastrectomy in type 2 diabetic patients.

DePaula AL, Stival AR, DePaula CC, Halpern A, Vêncio S.

J Gastrointest Surg. 2010 Aug;14(8):1319-25. doi: 10.1007/s11605-010-1252-5. Epub 2010 Jun 16.

PMID:
20556664
4.

Evolution of subclinical hypothyroidism and its relation with glucose and triglycerides levels in morbidly obese patients after undergoing sleeve gastrectomy as bariatric procedure.

Ruiz-Tovar J, Boix E, Galindo I, Zubiaga L, Diez M, Arroyo A, Calpena R.

Obes Surg. 2014 May;24(5):791-5. doi: 10.1007/s11695-013-1150-5.

PMID:
24347349
5.

Bariatric surgery versus intensive medical therapy in obese patients with diabetes.

Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, Thomas S, Abood B, Nissen SE, Bhatt DL.

N Engl J Med. 2012 Apr 26;366(17):1567-76. doi: 10.1056/NEJMoa1200225. Epub 2012 Mar 26.

6.

Improvement of insulin resistance and reduction of cardiovascular risk among obese patients with type 2 diabetes with the duodenojejunal bypass liner.

de Moura EG, Orso IR, Martins BC, Lopes GS, de Oliveira SL, Galvão-Neto Mdos P, Mancini MC, Santo MA, Sakai P, Ramos AC, Garrido-Júnior AB, Halpern A, Cecconello I.

Obes Surg. 2011 Jul;21(7):941-7. doi: 10.1007/s11695-011-0387-0.

PMID:
21442376
7.

Laparoscopic ileal interposition with diverted sleeve gastrectomy for treatment of type 2 diabetes.

Kota SK, Ugale S, Gupta N, Modi KD.

Diabetes Metab Syndr. 2012 Jul-Sep;6(3):125-31. doi: 10.1016/j.dsx.2012.09.014. Epub 2012 Oct 25.

PMID:
23158974
8.

Laparoscopic duodenojejunal bypass with sleeve gastrectomy: preliminary results of a prospective series from India.

Raj PP, Kumaravel R, Chandramaliteeswaran C, Vaithiswaran V, Palanivelu C.

Surg Endosc. 2012 Mar;26(3):688-92. doi: 10.1007/s00464-011-1938-0. Epub 2011 Oct 13.

PMID:
21993937
9.

Laparoscopic sleeve gastrectomy with duodenojejunal bypass for the treatment of type 2 diabetes in non-obese patients: technique and preliminary results.

Navarrete SA, Leyba JL, Llopis SN.

Obes Surg. 2011 May;21(5):663-7. doi: 10.1007/s11695-011-0371-8.

PMID:
21336559
10.

Laparoscopic treatment of metabolic syndrome in patients with type 2 diabetes mellitus.

DePaula AL, Macedo AL, Rassi N, Vencio S, Machado CA, Mota BR, Silva LQ, Halpern A, Schraibman V.

Surg Endosc. 2008 Dec;22(12):2670-8. doi: 10.1007/s00464-008-9808-0. Epub 2008 Mar 18.

PMID:
18347866
11.

Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion.

Lee WJ, Ser KH, Chong K, Lee YC, Chen SC, Tsou JJ, Chen JC, Chen CM.

Surgery. 2010 May;147(5):664-9. doi: 10.1016/j.surg.2009.10.059. Epub 2009 Dec 11.

PMID:
20004451
12.

Ileal interposition with sleeve gastrectomy for control of type 2 diabetes.

Kumar KV, Ugale S, Gupta N, Naik V, Kumar P, Bhaskar P, Modi KD.

Diabetes Technol Ther. 2009 Dec;11(12):785-9. doi: 10.1089/dia.2009.0070.

PMID:
20001679
13.

Midterm impact of sleeve gastrectomy, calibrated with a 50-Fr bougie, on weight loss, glucose homeostasis, lipid profiles, and comorbidities in morbidly obese patients.

Ruiz-Tovar J, Oller I, Tomas A, Llavero C, Arroyo A, Calero A, Martinez-Blasco A, Calpena R.

Am Surg. 2012 Sep;78(9):969-74.

PMID:
22964206
14.

Improvement in insulin sensitivity and β-cell function following ileal interposition with sleeve gastrectomy in type 2 diabetic patients: potential mechanisms.

De Paula AL, Stival AR, Halpern A, DePaula CC, Mari A, Muscelli E, Vencio S, Ferrannini E.

J Gastrointest Surg. 2011 Aug;15(8):1344-53. doi: 10.1007/s11605-011-1550-6. Epub 2011 May 10.

PMID:
21557013
15.

Novel metabolic surgery for type II diabetes mellitus: loop duodenojejunal bypass with sleeve gastrectomy.

Huang CK, Goel R, Tai CM, Yen YC, Gohil VD, Chen XY.

Surg Laparosc Endosc Percutan Tech. 2013 Dec;23(6):481-5. doi: 10.1097/SLE.0b013e3182950111.

PMID:
24300921
16.

Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21-29.

DePaula AL, Macedo AL, Mota BR, Schraibman V.

Surg Endosc. 2009 Jun;23(6):1313-20. doi: 10.1007/s00464-008-0156-x. Epub 2008 Oct 2.

PMID:
18830750
17.

Long-term remission of type 2 diabetes in morbidly obese patients after sleeve gastrectomy.

Abbatini F, Capoccia D, Casella G, Soricelli E, Leonetti F, Basso N.

Surg Obes Relat Dis. 2013 Jul-Aug;9(4):498-502. doi: 10.1016/j.soard.2012.09.003. Epub 2012 Sep 18.

PMID:
23290187
18.

Effect of sleeve gastrectomy on postprandial lipoprotein metabolism in morbidly obese patients.

Waldmann E, Hüttl TP, Göke B, Lang R, Parhofer KG.

Lipids Health Dis. 2013 Jun 1;12:82. doi: 10.1186/1476-511X-12-82.

20.

The impact of pioglitazone on glycemic control and atherogenic dyslipidemia in patients with type 2 diabetes mellitus.

Rosenblatt S, Miskin B, Glazer NB, Prince MJ, Robertson KE; Pioglitazone 026 Study Group.

Coron Artery Dis. 2001 Aug;12(5):413-23.

PMID:
11491207
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk